CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...
MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the ...
For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...
New funding to fuel market expansion of compute efficient foundation model for biopharmaceutical companies VANCOUVER, British Columbia–(BUSINESS WIRE)–February 20, 2025– Variational AI, the company ...
The U.S. Food and Drug Administration’s recently published Roadmap to Reducing Animal Testing in Preclinical Safety Studies may have caused a stir across the pharmaceutical and biotech industries, but ...
Javelin, a pioneer in human-centric preclinical drug discovery, today announced the appointment of Robin Robinson, PhD to its Board of Directors, effective February 2025. This strategic addition comes ...
Liam Taylor, CEO, Axol Bioscience "We have built a unique set of products and services over the last decade to meet the growing requirements from the drug discovery and cosmetic industries to move ...
Tahoe Therapeutics Raises $30M to Build World’s Largest Dataset for Training AI Models of Human Cell
SAN FRANCISCO--(BUSINESS WIRE)--Tahoe Therapeutics today announced $30 million in new funding to build the definitive foundational dataset for training Virtual Cell Models. With this, the team will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback